Rare Disease Treatment Market to Achieve USD 228.34 Billion by 2028, Showcasing a Compound Annual Growth Rate of 11.08% Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Rare Disease Treatment Market (2023-2028) by Therapeutic Area, Drug Type, Drug Class, Mode of Administration, Distribution Channel, and...

With a CAGR of 11.8%, the Global Rare Disease Drug Market is forecast to reach a Market Value of US$ 270 billion by 2028 – Market Report by RationalStat Wilmington, Delaware, July 26, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s analysis, Global Rare Disease Drug Market was estimated at a market value of US$ 192 billion in 2022 and is...

Global Rare Disease Drugs Market Report 2022: Market Value to Double in Just 5 Years, from $161 Billion in 2022 to $326 Billion in 2027 Dublin, Dec. 06, 2022 (GLOBE NEWSWIRE) -- The "Global Rare Disease Drugs Market (2022 Edition) - Analysis By Drug Type, Therapeutic Area, Patients, Route of Administration, Distribution Channel, By...

Insights on the Rare Diseases Treatment Global Market to 2028 - Players Include AbbVie, F. Hoffmann-La Roche, Bayer, Novartis and Merck Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy,...

Worldwide Rare Disease Drug Global Industry to 2026 - by Manufacturers, Regions, Technology, Application and Product Type Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Rare Disease Drug Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report...